Charles River Laboratories International (CRL) EBITDA Margin Growth (3y) (2012 - 2025)
Charles River Laboratories International (CRL) EBITDA Margin Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -2,915.00 |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 233.00 |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -292.00 |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 63.00 |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 4,255.00 |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -56.00 |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -51.00 |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 2,504.00 |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -73.00 |
| 10 | Charles River Laboratories International | 11.36 Bn | 11.15 Bn | 744.94 Mn | -4,340.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -4,340.00 |
| Sep 27, 2025 | -195.00 |
| Jun 28, 2025 | -956.00 |
| Mar 29, 2025 | -869.00 |
| Dec 28, 2024 | -3,582.00 |
| Sep 28, 2024 | -576.00 |
| Jun 29, 2024 | -26.00 |
| Mar 30, 2024 | -255.00 |
| Dec 30, 2023 | -318.00 |
| Sep 30, 2023 | -310.00 |
| Jul 1, 2023 | 432.00 |
| Apr 1, 2023 | 298.00 |
| Dec 31, 2022 | -85.00 |
| Sep 24, 2022 | 137.00 |
| Jun 25, 2022 | 713.00 |
| Mar 26, 2022 | 473.00 |
| Dec 25, 2021 | 206.00 |
| Sep 25, 2021 | 298.00 |
| Jun 26, 2021 | 193.00 |
| Mar 27, 2021 | 127.00 |